Community Survey Results Show that Standardisation of Preclinical Imaging Techniques Remains a Challenge

Abstract Purpose To support acquisition of accurate, reproducible and high-quality preclinical imaging data, various standardisation resources have been developed over the years. However, it is unclear the impact of those efforts in current preclinical imaging practices. To better understand the status quo in the field of preclinical imaging standardisation, the STANDARD group of the European Society of Molecular Imaging (ESMI) put together a community survey and a forum for discussion at the European Molecular Imaging Meeting (EMIM) 2022. This paper reports on the results from the STANDARD survey and the forum discussions that took place at EMIM2022. Procedures The survey was delivered to the community by the ESMI office and was promoted through the Society channels, email lists and webpages. The survey contained seven sections organised as generic questions and imaging modality-specific questions. The generic questions focused on issues regarding data acquisition, data processing, data storage, publishing and community awareness of international guidelines for animal research. Specific questions on practices in optical imaging, PET, CT, SPECT, MRI and ultrasound were further included. Results Data from the STANDARD survey showed that 47% of survey participants do not have or do not know if they have QC/QA guidelines at their institutes. Additionally, a large variability exists in the ways data are acquired, processed and reported regarding general aspects as well as modality-specific aspects. Moreover, there is limited awareness of the existence of international guidelines on preclinical (imaging) research practices. Conclusions Standardisation of preclinical imaging techniques remains a challenge and hinders the transformative potential of preclinical imaging to augment biomedical research pipelines by serving as an easy vehicle for translation of research findings to the clinic. Data collected in this project show that there is a need to promote and disseminate already available tools to standardise preclinical imaging practices. </jats:sec

Community survey results show that standardisation of preclinical imaging techniques remains a challenge

PURPOSE: To support acquisition of accurate, reproducible and high-quality preclinical imaging data, various standardisation resources have been developed over the years. However, it is unclear the impact of those efforts in current preclinical imaging practices. To better understand the status quo in the field of preclinical imaging standardisation, the STANDARD group of the European Society of Molecular Imaging (ESMI) put together a community survey and a forum for discussion at the European Molecular Imaging Meeting (EMIM) 2022. This paper reports on the results from the STANDARD survey and the forum discussions that took place at EMIM2022. PROCEDURES: The survey was delivered to the community by the ESMI office and was promoted through the Society channels, email lists and webpages. The survey contained seven sections organised as generic questions and imaging modality-specific questions. The generic questions focused on issues regarding data acquisition, data processing, data storage, publishing and community awareness of international guidelines for animal research. Specific questions on practices in optical imaging, PET, CT, SPECT, MRI and ultrasound were further included. RESULTS: Data from the STANDARD survey showed that 47% of survey participants do not have or do not know if they have QC/QA guidelines at their institutes. Additionally, a large variability exists in the ways data are acquired, processed and reported regarding general aspects as well as modality-specific aspects. Moreover, there is limited awareness of the existence of international guidelines on preclinical (imaging) research practices. CONCLUSIONS: Standardisation of preclinical imaging techniques remains a challenge and hinders the transformative potential of preclinical imaging to augment biomedical research pipelines by serving as an easy vehicle for translation of research findings to the clinic. Data collected in this project show that there is a need to promote and disseminate already available tools to standardise preclinical imaging practices

SYDDARTA: new methodology for digitization of deterioration estimation in paintings

ABSTRACT The SYDDARTA project is an on-going European Commission funded initiative under the 7th Framework Programme. Its main objective is the development of a pre-industrial prototype for diagnosing the deterioration of movable art assets. The device combines two different optical techniques for the acquisition of data. On one hand, hyperspectral imaging is implemented by means of electronically tunable filters. On the other, 3D scanning, using structured light projection and capturing is developed. These techniques are integrated in a single piece of equipment, allowing the recording of two optical information streams. Together with multi-sensor data merging and information processing, estimates of artwork deterioration and degradation can be made. In particular, the resulting system will implement two optical channels (3D scanning and short wave infrared (SWIR) hyperspectral imaging) featuring a structured light projector and electronically tunable spectral separators. The system will work in the VIS-NIR range (400-1000nm), and SWIR range (900-2500nm). It will be also portable and user-friendly. Among all possible art work under consideration, Baroque paintings on canvas and wooden panels were selected as the project case studies

Neurobiological insights from bioluminescence imaging

Neuro Imaging Researc

Noninvasive multimodal imaging of stem cell transplants in the brain using bioluminescence imaging and magnetic resonance imaging

© Springer Science+Business Media New York 2013

Initial graft size and not the innate immune response limit survival of engrafted neural stem cells

Neuro Imaging Researc

Targeted nanoparticles for the non-invasive detection of traumatic brain injury by optical imaging and fluorine magnetic resonance imaging

Imaging- and therapeutic targets in neoplastic and musculoskeletal inflammatory diseas